Isolation of deoxycoformycin-resistant cells with increased levels of adenosine deaminase.
Deoxycoformycin (dCF) is a specific inhibitor of adenosine deaminase (ADA). Rat hepatoma cells deficient in adenosine kinase and growing on adenosine as the sole carbon source are sensitive to the lethal action of dCF. Mutants resistant to dCF arise spontaneously with a frequency of 1.7 x 10(-6). This frequency is increased to 2.6 x 10(-5) by prior mutagenesis with ethyl methane sulfonate. Initially, dCF-resistant cell lines have 3-10 times the level of adenosine deaminase when compared to sensitive parental cells. Subsequent selection of mutants resistant to increased concentrations of dCF results in cells with a 15- to 30-fold increase in ADA levels. Quantitative immunoprecipitation tests indicate that the increase in enzyme activity in one line tested is due to an increase in the number of ADA molecules. These dCF' cell lines may serve as a model system to study the human disease state, hereditary hemolytic anemia, which is associated with increased levels of ADA.
D000243:Adenosine Deaminase / Q000235:genetics* / Q000378:metabolism; D000818:Animals; D002460:Cell Line; D002469:Cell Separation / Q000379:methods*; D003070:Coformycin / Q000031:analogs & derivatives / Q000494:pharmacology*; D004351:Drug Resistance; D007700:Kinetics; D008114:Liver Neoplasms, Experimental; D009154:Mutation; D009700:Nucleoside Deaminases / Q000235:genetics*; D015649:Pentostatin; D051381:Rats; D012263:Ribonucleosides / Q000494:pharmacology*
D012263:Ribonucleosides; D003070:Coformycin; D015649:Pentostatin; D009700:Nucleoside Deaminases; D000243:Adenosine Deaminase